261 related articles for article (PubMed ID: 32485671)
1. 90 YEARS OF PROGESTERONE: Molecular mechanisms of progesterone receptor action on the breast cancer genome.
Beato M; Wright RHG; Dily FL
J Mol Endocrinol; 2020 Jul; 65(1):T65-T79. PubMed ID: 32485671
[TBL] [Abstract][Full Text] [Related]
2. More help than hindrance: nucleosomes aid transcriptional regulation.
Ballaré C; Zaurin R; Vicent GP; Beato M
Nucleus; 2013; 4(3):189-94. PubMed ID: 23756349
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.
Archer TK; Fryer CJ; Lee HL; Zaniewski E; Liang T; Mymryk JS
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):421-9. PubMed ID: 7626491
[TBL] [Abstract][Full Text] [Related]
4. Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin.
Vicent GP; Nacht AS; Zaurín R; Ballaré C; Clausell J; Beato M
Mol Endocrinol; 2010 Nov; 24(11):2088-98. PubMed ID: 20484412
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
Deroo BJ; Archer TK
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
7. Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.
Proietti CJ; Cenciarini ME; Elizalde PV
Steroids; 2018 May; 133():75-81. PubMed ID: 29317254
[TBL] [Abstract][Full Text] [Related]
8. Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes.
Vicent GP; Nacht AS; Zaurin R; Font-Mateu J; Soronellas D; Le Dily F; Reyes D; Beato M
Genes Dev; 2013 May; 27(10):1179-97. PubMed ID: 23699411
[TBL] [Abstract][Full Text] [Related]
9. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
Lee KI; Reddy EP; Reddy CD
J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
[TBL] [Abstract][Full Text] [Related]
10. Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.
Subtil-Rodríguez A; Millán-Ariño L; Quiles I; Ballaré C; Beato M; Jordan A
Mol Cell Biol; 2008 Jun; 28(11):3830-49. PubMed ID: 18378698
[TBL] [Abstract][Full Text] [Related]
11. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of context-dependent progesterone receptor action in breast cancer.
Hagan CR; Lange CA
BMC Med; 2014 Feb; 12():32. PubMed ID: 24552158
[TBL] [Abstract][Full Text] [Related]
13. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways.
Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M
Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755
[TBL] [Abstract][Full Text] [Related]
14. C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.
Nacht AS; Ferrari R; Zaurin R; Scabia V; Carbonell-Caballero J; Le Dily F; Quilez J; Leopoldi A; Brisken C; Beato M; Vicent GP
EMBO J; 2019 Sep; 38(18):e101426. PubMed ID: 31373033
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
Yin P; Roqueiro D; Huang L; Owen JK; Xie A; Navarro A; Monsivais D; Coon JS; Kim JJ; Dai Y; Bulun SE
PLoS One; 2012; 7(1):e29021. PubMed ID: 22272226
[TBL] [Abstract][Full Text] [Related]
16. Cloning and functional characterization of human Pak1 promoter by steroid hormones.
Raghavan S; Venkatraman G; Rayala SK
Gene; 2018 Mar; 646():120-128. PubMed ID: 29274909
[TBL] [Abstract][Full Text] [Related]
17. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
18. Steroid hormones, steroid receptors, and breast cancer stem cells.
Finlay-Schultz J; Sartorius CA
J Mammary Gland Biol Neoplasia; 2015 Jun; 20(1-2):39-50. PubMed ID: 26265122
[TBL] [Abstract][Full Text] [Related]
19. Two chromatin remodeling activities cooperate during activation of hormone responsive promoters.
Vicent GP; Zaurin R; Nacht AS; Li A; Font-Mateu J; Le Dily F; Vermeulen M; Mann M; Beato M
PLoS Genet; 2009 Jul; 5(7):e1000567. PubMed ID: 19609353
[TBL] [Abstract][Full Text] [Related]
20. Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.
Rayasam GV; Elbi C; Walker DA; Wolford R; Fletcher TM; Edwards DP; Hager GL
Mol Cell Biol; 2005 Mar; 25(6):2406-18. PubMed ID: 15743833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
